Erratum: Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC [Corrigendum]

Abstract

[This corrects the article DOI: 10.2147/IJN.S258906.].

Figure 6

Inhibitory effects on VM channels formation and angiogenesis after treatment with varying liposomal formulations. (A) Inhibition of VM channels formation in vitro, scale bar=50 μm; (B) quantitative analysis of the number of VM channels; (C) inhibition of angiogenesis on CAM after treatment with the varying liposomal formulations, scale bar=5 mm; (D) analysis of relative area vessels after treatment with the varying liposomal formulations. Data are presented as mean±SD (n=6). a. Blank control; b. Dioscin liposomes; c. Vinorelbine liposomes; d. Vinorelbine plus dioscin liposomes; e. CPP _(mmp) modified vinorelbine plus dioscin liposomes; f. CPP _(mmp) modified vinorelbine plus dioscin liposomes incubated with MMP2 enzymes; 1, vs a; 2, vs b; 3, vs c; 4, vs d; 5, vs e. P<0.05.